About Ergomed
Ergomed is a Healthcare company based in Houston (United States) founded in 1997, and was acquired by Ergomed in December 2020. Full-service CRO operations are focused on oncology and complex trials. It operates on a Professional Services and Managed Services model. Ergomed has completed 1 acquisition, including Datatrial. Ergomed offers products and services including Ergomed CAREâ„¢, Clinical Development Strategy, and Oncology Trial Solutions. Its focus areas include Biotechnology and Clinical Research Organizations. Its legal entity is Ergomed Group. Its competitors include Emmes, Syneos Health and Veristat.
Company details
Ergomed is established as a global Contract Research Organization (CRO) focused on delivering high-quality clinical research services. Expertise is provided in oncology, rare diseases, and complex trials involving vulnerable populations. Tailored solutions are offered for trial design, regulatory guidance, and patient-centric approaches through proprietary systems like Ergomed CARE. Services span clinical development strategy, site management, and biometrics, ensuring efficient trial execution. Operations are supported across over 100 countries, with a strong U.S. presence in Raleigh and Boston, facilitating responsive clinical development for sponsors worldwide.
Products & Services of Ergomed
Ergomed offers a comprehensive portfolio of products and services, including Ergomed CARE™, Clinical Development Strategy, and Oncology Trial Solutions.
Patient enrollment and engagement are improved through innovative solutions.
Strategic guidance is provided for clinical trial development success.
Specialized solutions are offered for complex oncology clinical trials.
Apps and channels of Ergomed
its YouTube channel Ergomed Group has 568 subscribers and 30 videos.
Videos from Ergomed
The most watched videos on Ergomed's YouTube channel, Ergomed Group (568 subscribers). Click a video to play it here.
More on Ergomed Group.
Investors in Ergomed
Ergomed has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ergomed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Clinical CRO services for oncology and rare diseases are provided. | 1997 | ergomedplc.com | Guildford, United Kingdom |
Investor details for Ergomed
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ergomed
Ergomed has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Datatrial.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Datatrial operate in the life science sector offering our proprietary EDC system (nowEDC™), data management, bio-statistical and consulting services | datatrial.com | Newcastle Upon Tyne, United Kingdom | 1999 | Jun 2017 | •••• |
Complete acquisition details for Ergomed
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Competitors of Ergomed
Ergomed has 3 listed competitors in our database. They include Emmes, Syneos Health and Veristat.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| emmes.com | 1977 | United States | 195 | Outsourced contract research organization services are provided to clients. | ||
| syneoshealth.com | 1984 | Raleigh, United States | 29,395 | CRO clinical development services are provided by Syneos Health. | ||
| veristat.com | 1994 | Southborough, United States | 7 | Clinical trials and regulatory submissions are supported as a CRO. |
Detailed competitors of Ergomed
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Ergomed
The website of Ergomed (medsource.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▲ 128.1% vs previous month
Websites whose visitors overlap most with Ergomed. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| siroclinpharm.com | 100% | 2.1K | #10,091,033 | View details | |
| emissary.com | 99% | View details | |||
| quanticate.com | 99% | #1,287,633 | View details | ||
| lambda-cro.com | 99% | 38.8K | #490,207 | View details | |
medevol.com | medevol.com | 62% | – |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Ergomed (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ergomed
Complete news archive for Ergomed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ergomed
Ergomed was founded in 1997.
Ergomed is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Ergomed is established as a global Contract Research Organization (CRO) focused on delivering high-quality clinical research services. Expertise is provided in oncology, rare diseases, and complex trials involving vulnerable populations. Tailored solutions are offered for trial design, regulatory guidance, and patient-centric approaches through proprietary systems like Ergomed CARE. Services span clinical development strategy, site management, and biometrics, ensuring efficient trial execution. Operations are supported across over 100 countries, with a strong U.S. presence in Raleigh and Boston, facilitating responsive clinical development for sponsors worldwide.
Ergomed's top competitors include Emmes, Syneos Health and Veristat.
Ergomed offers Ergomed CAREâ„¢, Clinical Development Strategy, and Oncology Trial Solutions.
Ergomed has made 1 acquisition, including Datatrial.
Ergomed has 1 investor. Key investors include Ergomed.
Ergomed operates through Ergomed Group.
Yes. Ergomed was acquired by Ergomed in December 2020.